Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Assessing the toxicity after moderately hypofractionated prostate and whole pelvis radiotherapy compared to conventional fractionation ; day:21 ; month:6 ; year:2023 ; pages:1-7
Strahlentherapie und Onkologie ; (21.6.2023), 1-7
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00066-023-02104-7
- URN
-
urn:nbn:de:101:1-2023092210061914485135
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Moll, Matthias
- Goldner, Gregor
- SpringerLink (Online service)
Other Objects (12)
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Normofractionated and moderately hypofractionated proton therapy : Comparison of acute toxicity and early quality of life outcomes
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Normofractionated and moderately hypofractionated proton therapy : Comparison of acute toxicity and early quality of life outcomes
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment
Correction: Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis
Normofractionated and moderately hypofractionated proton therapy : Comparison of acute toxicity and early quality of life outcomes
Hypofractionated versus standard fractionation radiotherapy for merkel cell carcinoma
Long-term outcomes of moderately hypofractionated radiotherapy (67.5 Gy in 25 fractions) for prostate cancer confined to the pelvis: a single center retrospective analysis
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
Impact of planning organ at risk volume margins and matching method on late gastrointestinal toxicity in moderately hypofractionated IMRT for locally advanced pancreatic ductal adenocarcinoma
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation
Acute toxicity profile in prostate cancer with conventional and hypofractionated treatment